Insider Transactions in Q1 2023 at Vyne Therapeutics Inc. (VYNE)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
480
-4.42%
|
$1,440
$3.08 P/Share
|
|
Mar 31
2023
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
384
-4.52%
|
$1,152
$3.08 P/Share
|
|
Mar 31
2023
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,734
-5.12%
|
$8,202
$3.08 P/Share
|
|
Mar 31
2023
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
478
-2.1%
|
$1,434
$3.08 P/Share
|
|
Mar 20
2023
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
BUY
Open market or private purchase
|
Direct |
10,000
+30.56%
|
$20,000
$2.5 P/Share
|
|
Mar 20
2023
|
Patrick G Lepore Director |
BUY
Open market or private purchase
|
Direct |
20,000
+46.01%
|
$40,000
$2.48 P/Share
|